An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancerSia V. Lindskrog, Lars Dyrskjøt, Iver Nordentoft et al.|Nature Communications|2021Cited by 381
Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysisAnn Taber, Lars Dyrskjøt, Emil Christensen et al.|Nature Communications|2020Cited by 216
Multiomics profiling of urothelial carcinoma in situ reveals CIS-specific gene signature and immune characteristicsMeenakshi Anurag, Seth P. Lerner, Trine Strandgaard et al.|iScience|2024Cited by 12
An integrated multi-omics analysis identifies clinically relevant molecular subtypes of non-muscle-invasive bladder cancerSia V. Lindskrog, Lars Dyrskjøt, Frederik Prip et al.|medRxiv|2020Cited by 10